Navigation Links
Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
Date:7/27/2010

SEATTLE, July 27 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.  OMS302, added to standard irrigation solution used during ophthalmologic surgery, is Omeros' proprietary PharmacoSurgery™ product in development to maintain mydriasis (pupil dilation) and reduce postoperative pain and inflammation following cataract and other lens replacement surgery.

"Building on the solid foundation of the Phase 1/Phase 2 OMS302 data reported last year, we are pleased to enroll the first patient in our Phase 2b trial, which is using a full-factorial design to compare the individual agents in OMS302 to the proprietary drug product itself," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "There are over three million cataract procedures performed annually in the U.S. alone, and OMS302 has the potential to maintain pupil dilation, making the operation easier for the surgeon and safer for the patient, and to reduce postoperative inflammation, improving patient outcomes."

Approximately 200 patients will be enrolled in the multicenter, randomized, double-blind, vehicle-controlled Phase 2b clinical trial. Patients will be randomized into one of four parallel treatment groups of equal size. The first arm will receive OMS302, the second and third will receive only the mydriatic agent and the anti-inflammatory agent, respectively, and the fourth arm will
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Successfully Unlocks Orphan GPCRs
2. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
3. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
4. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
5. Daniel K. Spiegelman Elected to Board of Directors of Omeros
6. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
7. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
8. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
9. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
10. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
11. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Doctors from the Sheikh Zayed ... National Health System are the first in ... osteoma, a benign but painful bone tumor that commonly ... magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) method. Two patients, ... Shah , have been treated successfully in a research ...
(Date:5/27/2015)... 2015 The report " Tube Packaging Market ... Oral Care, Food & beverages, Pharmaceuticals, Consumer Goods), by Material ... - Trends & Forecasts to 2020", published by MarketsandMarkets, The ... a CAGR of 6.65% from 2015, to reach $8,638.9 Million ... Tables and   61 F igures spread thro ...
(Date:5/27/2015)... , May 27, 2015  Vital Access Corp. announced ... credit facility with Deerfield Management, a healthcare investment firm. ... Vital Access, continued global expansion of its innovative VWING™ ... the Company,s proprietary vascular access platform. "Vital ... financial partner. Deerfield is a healthcare investor with great ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Tube Packaging Market Worth $8.63 Billion by 2020 2Tube Packaging Market Worth $8.63 Billion by 2020 3Tube Packaging Market Worth $8.63 Billion by 2020 4Vital Access Receives $10 Million Financing Commitment from Deerfield 2Vital Access Receives $10 Million Financing Commitment from Deerfield 3
(Date:5/27/2015)... Bedford, New Hampshire (PRWEB) May 27, 2015 ... published in the April 2015 issue of the Journal ... of diet sodas and abdominal obesity, Bedford Commons ... consuming water instead of non-nutritive sweetener-flavored beverages. , ... long-term waist circumference, a comprehensive San Antonio Longitudinal Study ...
(Date:5/27/2015)... The MedSpa at Hendrick is excited to ... in Abilene, Texas: Xeomin®, Belotero Balance® and Radiesse®. , ... lines, better known as the lines between the eyebrows ... treat smoker’s lines around the mouth and marionette lines ... the appearance of smile lines or lines around the ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CompanionDx ... pharmacogenomic and somatic genomic analysis in personalized cancer therapy: ... by the American Society of Clinical Oncology (ASCO) as ... 2 in Chicago. , The molecular and clinical data ... Genome Atlas (TCGA) database. The study reports improved patient ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in ... Foundation is proud to host the first annual Women Veterans ... 11 at the Freedom Center from 6 p.m. to 10 ... emcee. , This event honors and celebrates women tri-state ... The banquet is free to the first 150 women Veterans ...
(Date:5/27/2015)... Rolling Meadows, IL (PRWEB) May 27, 2015 ... the release of its SonarMD Platform, a ... engaging, monitoring and managing patients with chronic ... Lawrence Kosinski, MD, MBA, the application allows ... between visits through the ongoing use of ...
Breaking Medicine News(10 mins):Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
... years or longer before currently available blood tests will detect ... of Medicine scientists indicates. The analysis, which was restricted to ... types, will be published online Nov. 16 in Science ... as both bad and good news," said Sanjiv "Sam" Gambhir, ...
... of Orthopaedic Surgeons (AAOS) Board of Directors has recently ... on "The Treatment of Supracondylar Humerus Fractures." ... of the Trauma Program at the University of Toronto ... AAOS Work Group responsible for this CPG, said that ...
... --- In 2020, the vast majority of adults in America ... suffer from diabetes or pre-diabetic conditions, according to projections presented ... Scientific Sessions Wednesday, Nov. 16, in Orlando. The ... overall heart health by 20 percent in 2020. However, if ...
... a breathtaking technological revolution that promises remarkable new ways ... the release of dangerous nanoparticles, nanorobots or nanoelectronic devices ... review of more than 500 studies on the topic ... ACS, journal Molecular Pharmaceutics . Ruth Duncan ...
... less produce the finest foie gras that rich, buttery ... eaten as slices atop lightly toasted bread scientists are ... and Food Chemistry. Caroline Molette and colleagues explain ... gras, a traditional French dish, comes from its high fat ...
... issues facing lesbian, gay, bisexual and transgender baby boomers ... These seniors face higher rates of disability, physical and ... according to the first study on aging and health ... and led by Karen Fredriksen-Goldsen and colleagues at the ...
Cached Medicine News:Health News:New Stanford model establishes guidelines for earlier cancer detection 2Health News:New Stanford model establishes guidelines for earlier cancer detection 3Health News:New Stanford model establishes guidelines for earlier cancer detection 4Health News:AAOS issues new clinical practice guideline for treating common elbow fractures in children 2Health News:On track to getting even fatter 2Health News:On track to getting even fatter 3Health News:LGBT seniors face harder old age, national study finds 2Health News:LGBT seniors face harder old age, national study finds 3
... versatility that a second mirror adds, then you ... It features the same 1.5x magnification as the ... 60 and 64 respectively. Available in standard (flange) ... the "Flanged" model for laser use. ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 15° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
... 15° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
Medicine Products: